Srinibas Pradhan Constructions IPO...
28 Feb, 2026
Kronox Lab Sciences Limited IPO
Kronox Lab Sciences Ltd. is a bulk manufacturer of high purity fine chemicals, in compliance with Reagent, Pharmacopoeia and various Food Grade standards, for the pharmaceutical, nutraceutical, veterinary, food, chemical analysis and other specialty markets. With large manufacturing facilities, modern Quality Control standards and advanced Research and Development Department, KRONOX Lab Sciences Ltd. is geared to produce high purity fine chemicals at the facilities located at Padra, Baroda, Gujarat, INDIA.
Kronox Lab Sciences IPO is a book-built issue of Rs 130.15 crores. The issue is entirely an offer for sale of 0.96 crore shares. Kronox Lab Sciences IPO opens for subscription on June 3, 2024 and closes on June 5, 2024. Kronox Lab Sciences IPO price band is set at ₹129 to ₹136 per share. The minimum lot size for an application is 110 Shares. Pantomath Capital Advisors Pvt Ltd is the book running lead manager of the Kronox Lab Sciences IPO, while Kfin Technologies Limited is the registrar for the issue.
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Kronox Lab Sciences Limited IPO GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Kronox Lab Sciences Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | June 3, 2024 to June 5, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹129 to ₹136 per share |
| Lot Size | 110 Shares |
| Total Issue Size | 9,570,000 shares (aggregating up to ₹130.15 Cr) |
| Offer for Sale | 9,570,000 shares of ₹10 (aggregating up to ₹130.15 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 37,104,000 |
| Share holding post issue | 37,104,000 |
Kronox Lab Sciences Limited IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | Monday, June 3, 2024 |
| IPO Close Date | Wednesday, June 5, 2024 |
| Basis of Allotment | Thursday, June 6, 2024 |
| Initiation of Refunds | Friday, June 7, 2024 |
| Credit of Shares to Demat | Friday, June 7, 2024 |
| Listing Date | Monday, June 10, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 5, 2024 |
Kronox Lab Sciences Limited IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 110 | ₹14,960 |
| Retail (Max) | 13 | 1,430 | ₹194,480 |
| S-HNI (Min) | 14 | 1,540 | ₹209,440 |
| S-HNI (Max) | 66 | 7,260 | ₹987,360 |
| B-HNI (Min) | 67 | 7,370 | ₹1,002,320 |
Kronox Lab Sciences IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Kronox Lab Sciences Limited IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 99.98% | 74.21% |
Kronox Lab Sciences IPO Anchor Investors Details
| Bid Date | May 31, 2024 |
| Shares Offered | 2,871,000 |
| Anchor Portion Size (In Cr.) | 39.05 |
| Anchor lock-in period end date for 50% shares (30 Days) | July 6, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | September 4, 2024 |
Company & Financials
Incorporated in 2008, Kronox Lab Sciences Limited is a manufacturer of high-purity specialty fine chemicals for diverse end-user industries. The company's High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries and animal health products. The company offers a wide range of over 185 products, including phosphate, sulfate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate and others. These products are supplied to customers in India and more than 20 countries worldwide. The company exports its products to countries such as the United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others.
Competitive Strength:
- -
Kronox Lab Sciences Limited IPO Financial Information
| Period Ended | Assets | Total Income | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 2023 | 66.96 | 68.44 | 15.47 | 60.28 | - | - | ||||||||||||||||||||||||||||||||||
| 31 Mar 2023 | 54.03 | 97.50 | 16.62 | 44.68 | - | - | ||||||||||||||||||||||||||||||||||
| 31 Mar 2022 | 56.79 | 83.34 | 13.63 | 40.35 | - | 0.64 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2021 | 37.65 | 63.24 | 9.73 | 26.81 | - | 0.01 | ||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 25.66% |
| ROCE | 33.15% |
| RoNW | 25.66% |
| P/BV | 8.37 |
| PAT Margin (%) | 22.6 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 4.48 | 5.56 |
| P/E (x) | 30.37 | 24.47 |
Objectives of Kronox Lab Sciences IPO
The Objectives of the Offer are to:
- 1. Carry out the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders.
- 2. Achieve the benefits of listing the Equity Shares on the Stock Exchanges. Further, the Company expects that the proposed listing of the Equity Shares will enhance the visibility and brand image, provide liquidity to its existing Shareholders and provide a public market for Equity Shares in India.
Kronox Lab Sciences Limited IPO Review
The company is in the high-purity speciality chemical segment and enjoys virtual monopoly in certain products. Its product portfolio currently has 185 products and another 122 is in the pipeline. Based on FY24 annualized earnings, the issue appears fully priced. Investors may park funds for the medium to long term rewards.
RHP:
View RHPDRHP:
View DRHPRead more :
- 3C IT Solutions & Telecoms Limited IPO
- Sattrix Information Security Limited IPO
- Blue Water Logistics Limited IPO
Frequently Asked Questions (FAQs)
-
What is the Kronox Lab Sciences IPO?
Kronox Lab Sciences IPO is a main-board IPO. They are going to raise ₹130.15 Crores via IPO. The issue is priced at ₹129 to ₹136 per equity share. The IPO is to be listed on BSE & NSE.
-
When will the Kronox Lab Sciences IPO open?
The IPO is to open on June 3, 2024 for QIB, NII, and Retail Investors.
-
What is Kronox Lab Sciences IPO Investors Portion?
The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.
-
What is Kronox Lab Sciences IPO Size?
Kronox Lab Sciences IPO size is ₹130.15 crores.
-
What is the Kronox Lab Sciences IPO Price Band?
Kronox Lab Sciences IPO Price Band is ₹129 to ₹136.
-
What is Kronox Lab Sciences IPO Minimum and Maximum Lot Size?
The minimum bid is 110 Shares with ₹14,960 amount while the maximum bid is 13 shares with ₹194,480.
-
What is the Kronox Lab Sciences IPO Allotment Date?
Kronox Lab Sciences IPO allotment date is June 6, 2024.
-
What is the Kronox Lab Sciences IPO Listing Date?
Kronox Lab Sciences IPO listing date is June 10, 2024. The IPO is to be listed on BSE and NSE.
